Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1994 2
1995 3
1996 2
1997 2
1998 5
1999 2
2000 5
2002 6
2003 1
2004 3
2005 2
2006 1
2007 3
2008 5
2009 5
2010 3
2011 8
2012 4
2013 11
2014 17
2015 8
2016 12
2017 16
2018 18
2019 8
2020 18
2021 21
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Results by year
Filters applied: . Clear all
Page 1
Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients.
Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, Tulstrup M, Westergaard D, Ullum H, Brunak S, Tommerup N, Feenstra B, Geller F, Ostrowski SR, Grønbæk K, Nielsen CH, Nielsen SD, Feldt-Rasmussen U. Bliddal S, et al. Among authors: gronbaek k. Sci Rep. 2021 Jun 23;11(1):13153. doi: 10.1038/s41598-021-92045-x. Sci Rep. 2021. PMID: 34162913 Free PMC article.
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.
Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, Montano-Almendras CP, Husby S, Freiburghaus C, Ek S, Pedersen A, Niemann C, Räty R, Brown P, Geisler CH, Andersen MK, Guldberg P, Jerkeman M, Grønbæk K. Eskelund CW, et al. Among authors: gronbaek k. Blood. 2017 Oct 26;130(17):1903-1910. doi: 10.1182/blood-2017-04-779736. Epub 2017 Aug 17. Blood. 2017. PMID: 28819011 Free article.
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
Eskelund CW, Kolstad A, Jerkeman M, Räty R, Laurell A, Eloranta S, Smedby KE, Husby S, Pedersen LB, Andersen NS, Eriksson M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Workman CT, Garde C, Elonen E, Brown P, Grønbaek K, Geisler CH. Eskelund CW, et al. Among authors: gronbaek k. Br J Haematol. 2016 Nov;175(3):410-418. doi: 10.1111/bjh.14241. Epub 2016 Jul 5. Br J Haematol. 2016. PMID: 27378674
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial.
Jerkeman M, Eskelund CW, Hutchings M, Räty R, Wader KF, Laurell A, Toldbod H, Pedersen LB, Niemann CU, Dahl C, Kuitunen H, Geisler CH, Grønbæk K, Kolstad A. Jerkeman M, et al. Among authors: gronbaek k. Lancet Haematol. 2018 Mar;5(3):e109-e116. doi: 10.1016/S2352-3026(18)30018-8. Epub 2018 Jan 29. Lancet Haematol. 2018. PMID: 29396091 Clinical Trial.
The role of vitamin C in epigenetic cancer therapy.
Mikkelsen SU, Gillberg L, Lykkesfeldt J, Grønbæk K. Mikkelsen SU, et al. Among authors: gronbaek k. Free Radic Biol Med. 2021 Jul;170:179-193. doi: 10.1016/j.freeradbiomed.2021.03.017. Epub 2021 Mar 28. Free Radic Biol Med. 2021. PMID: 33789122 Review.
Epigenetic therapy in hematological cancers.
Dimopoulos K, Grønbaek K. Dimopoulos K, et al. Among authors: gronbaek k. APMIS. 2019 May;127(5):316-328. doi: 10.1111/apm.12906. Epub 2019 Mar 12. APMIS. 2019. PMID: 30859683 Review.
MicroRNAs and cancer.
Cowland JB, Hother C, Grønbaek K. Cowland JB, et al. Among authors: gronbaek k. APMIS. 2007 Oct;115(10):1090-106. doi: 10.1111/j.1600-0463.2007.apm_775.xml.x. APMIS. 2007. PMID: 18042145 Review.
Immune Mechanisms in Myelodysplastic Syndrome.
Glenthøj A, Ørskov AD, Hansen JW, Hadrup SR, O'Connell C, Grønbæk K. Glenthøj A, et al. Among authors: gronbaek k. Int J Mol Sci. 2016 Jun 15;17(6):944. doi: 10.3390/ijms17060944. Int J Mol Sci. 2016. PMID: 27314337 Free PMC article. Review.
191 results